Literature DB >> 1848615

Overview of cytomegalovirus infections in HIV-infected patients: current therapies and future strategies.

C S Crumpacker1, M Heath-Chiozzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1848615

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN： 0894-9255


× No keyword cloud information.
  4 in total

1.  Race and the treatment of cytomegalovirus retinitis in a cohort of patients with acquired immunodeficiency syndrome.

Authors:  A K Wutoh; J Hidalgo; J Bareta; W Rhee; R Beardsley; S Steidl
Journal:  J Natl Med Assoc       Date:  1998-04       Impact factor: 1.798

2.  Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.

Authors:  J Piret; A Désormeaux; H Cormier; J Lamontagne; P Gourde; J Juhász; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 3.  Minimising the dosage-limiting toxicities of foscarnet induction therapy.

Authors:  D T Jayaweera
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

4.  Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.

Authors:  I Yust; Z Fox; M Burke; A Johnson; D Turner; A Mocroft; C Katlama; B Ledergerber; P Reiss; O Kirk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-30       Impact factor: 3.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.